7Baggers
 Published on: 2025-11-15 01:30:34  newser.com Sat, 15 Nov 2025 07:30:34 GMT
 published on: 2025-11-14 19:57:13  newser.com Sat, 15 Nov 2025 01:57:13 GMT
 published on: 2025-11-14 19:31:07  newser.com Sat, 15 Nov 2025 01:31:07 GMT
 published on: 2025-11-14 13:31:45  newser.com Fri, 14 Nov 2025 19:31:45 GMT
 Carisma Therapeutics Inc. SEC 10-Q Report  TradingView Wed, 12 Nov 2025 21:40:41 GMT
 published on: 2025-11-10 01:25:06  newser.com Mon, 10 Nov 2025 07:25:06 GMT
 published on: 2025-11-05 23:03:14  newser.com Thu, 06 Nov 2025 05:03:14 GMT
 published on: 2025-11-04 04:49:38  newser.com Tue, 04 Nov 2025 10:49:38 GMT
 published on: 2025-11-04 01:56:16  newser.com Tue, 04 Nov 2025 07:56:16 GMT
 published on: 2025-11-04 01:26:12  newser.com Tue, 04 Nov 2025 07:26:12 GMT
 published on: 2025-11-03 08:37:16  newser.com Mon, 03 Nov 2025 14:37:16 GMT
 published on: 2025-11-03 06:30:43  newser.com Mon, 03 Nov 2025 12:30:43 GMT
 published on: 2025-11-03 06:13:14  newser.com Mon, 03 Nov 2025 12:13:14 GMT
 published on: 2025-11-02 23:32:47  newser.com Mon, 03 Nov 2025 07:32:47 GMT
 published on: 2025-11-03 00:48:11  newser.com Mon, 03 Nov 2025 06:48:11 GMT
 published on: 2025-11-03 00:23:09  newser.com Mon, 03 Nov 2025 06:23:09 GMT

Carisma Therapeutics, Inc.
(NASDAQ:CARM) 

CARM stock logo

Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. Its solutions are used to play a crucial role in the innate and adaptive immune response, and technology leverages advances in macrophage biology, chimeri...

Founded: 2016
Full Time Employees: 92
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends